PRTK Annual Current Liabilities
$37.39 M
+$6.09 M+19.46%
31 December 2022
Summary:
As of January 21, 2025, PRTK annual total current liabilities is $37.39 million, with the most recent change of +$6.09 million (+19.46%) on December 31, 2022. During the last 3 years, it has risen by +$13.19 million (+54.50%).PRTK Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRTK Quarterly Current Liabilities
$202.62 M
+$169.87 M+518.78%
30 June 2023
Summary:
As of January 21, 2025, PRTK quarterly total current liabilities is $202.62 million, with the most recent change of +$169.87 million (+518.78%) on June 30, 2023. Over the past year, it has increased by +$172.52 million (+573.15%).PRTK Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRTK Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +19.5% | +573.1% |
| 3 y3 years | +54.5% | +497.3% |
| 5 y5 years | +122.7% | +496.0% |
PRTK Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | at high | at high |
Paratek Pharmaceuticals Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| June 2023 | - | $202.62 M(+518.8%) |
| Mar 2023 | - | $32.74 M(-12.4%) |
| Dec 2022 | $37.39 M(+19.5%) | $37.39 M(-4.1%) |
| Sept 2022 | - | $38.98 M(+29.5%) |
| June 2022 | - | $30.10 M(+4.4%) |
| Mar 2022 | - | $28.84 M(-7.9%) |
| Dec 2021 | $31.30 M(+30.7%) | $31.30 M(+7.4%) |
| Sept 2021 | - | $29.15 M(+39.0%) |
| June 2021 | - | $20.98 M(-8.6%) |
| Mar 2021 | - | $22.96 M(-4.2%) |
| Dec 2020 | $23.95 M(-1.0%) | $23.95 M(+4.6%) |
| Sept 2020 | - | $22.90 M(-32.5%) |
| June 2020 | - | $33.92 M(-21.3%) |
| Mar 2020 | - | $43.11 M(+78.1%) |
| Dec 2019 | $24.20 M(+36.7%) | $24.20 M(-3.3%) |
| Sept 2019 | - | $25.02 M(+13.3%) |
| June 2019 | - | $22.08 M(+16.3%) |
| Mar 2019 | - | $18.98 M(+7.2%) |
| Dec 2018 | $17.71 M(+5.5%) | $17.71 M(-31.1%) |
| Sept 2018 | - | $25.70 M(-24.4%) |
| June 2018 | - | $33.99 M(+45.5%) |
| Mar 2018 | - | $23.36 M(+39.2%) |
| Dec 2017 | $16.79 M(-17.7%) | $16.79 M(+6.3%) |
| Sept 2017 | - | $15.80 M(+5.1%) |
| June 2017 | - | $15.03 M(-19.4%) |
| Mar 2017 | - | $18.64 M(-8.7%) |
| Dec 2016 | $20.41 M(-0.4%) | $20.41 M(-6.2%) |
| Sept 2016 | - | $21.75 M(-23.7%) |
| June 2016 | - | $28.49 M(+9.6%) |
| Mar 2016 | - | $25.99 M(+26.8%) |
| Dec 2015 | $20.50 M(+448.0%) | $20.50 M(+50.7%) |
| Sept 2015 | - | $13.61 M(+19.7%) |
| June 2015 | - | $11.37 M(+56.1%) |
| Mar 2015 | - | $7.28 M(+94.7%) |
| Dec 2014 | $3.74 M | $3.74 M(+41.8%) |
| Sept 2014 | - | $2.64 M(+5.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2014 | - | $2.49 M(+28.7%) |
| Mar 2014 | - | $1.94 M(+0.4%) |
| Dec 2013 | $1.93 M(-27.6%) | $1.93 M(-37.0%) |
| Sept 2013 | - | $3.06 M(+126.5%) |
| June 2013 | - | $1.35 M(-36.1%) |
| Mar 2013 | - | $2.11 M(-20.6%) |
| Dec 2012 | $2.66 M(-20.2%) | $2.66 M(-21.0%) |
| Sept 2012 | - | $3.37 M(+8.1%) |
| June 2012 | - | $3.12 M(+20.1%) |
| Mar 2012 | - | $2.60 M(-22.2%) |
| Dec 2011 | $3.34 M(-65.4%) | $3.34 M(+42.6%) |
| Sept 2011 | - | $2.34 M(-37.2%) |
| June 2011 | - | $3.73 M(-40.9%) |
| Mar 2011 | - | $6.31 M(-34.6%) |
| Dec 2010 | $9.65 M(-40.0%) | $9.65 M(-30.7%) |
| Sept 2010 | - | $13.92 M(-8.7%) |
| June 2010 | - | $15.24 M(+0.9%) |
| Mar 2010 | - | $15.11 M(-6.1%) |
| Dec 2009 | $16.09 M(+198.4%) | $16.09 M(+2.9%) |
| Sept 2009 | - | $15.63 M(+318.9%) |
| June 2009 | - | $3.73 M(-20.4%) |
| Mar 2009 | - | $4.69 M(-13.0%) |
| Dec 2008 | $5.39 M(-71.9%) | $5.39 M(+18.9%) |
| Sept 2008 | - | $4.54 M(-7.4%) |
| June 2008 | - | $4.90 M(-91.7%) |
| Mar 2008 | - | $59.30 M(+209.4%) |
| Dec 2007 | $19.17 M(+207.1%) | $19.17 M(+0.6%) |
| Sept 2007 | - | $19.04 M(-11.4%) |
| June 2007 | - | $21.49 M(+175.2%) |
| Mar 2007 | - | $7.81 M(+25.2%) |
| Dec 2006 | $6.24 M(+33.3%) | $6.24 M(+2.0%) |
| Sept 2006 | - | $6.12 M(-0.3%) |
| June 2006 | - | $6.14 M(-2.5%) |
| Mar 2006 | - | $6.29 M(+34.4%) |
| Dec 2005 | $4.68 M(+73.5%) | $4.68 M(+73.5%) |
| Dec 2004 | $2.70 M | $2.70 M |
FAQ
- What is Paratek Pharmaceuticals annual total current liabilities?
- What is the all time high annual current liabilities for Paratek Pharmaceuticals?
- What is Paratek Pharmaceuticals annual current liabilities year-on-year change?
- What is Paratek Pharmaceuticals quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Paratek Pharmaceuticals?
- What is Paratek Pharmaceuticals quarterly current liabilities year-on-year change?
What is Paratek Pharmaceuticals annual total current liabilities?
The current annual current liabilities of PRTK is $37.39 M
What is the all time high annual current liabilities for Paratek Pharmaceuticals?
Paratek Pharmaceuticals all-time high annual total current liabilities is $37.39 M
What is Paratek Pharmaceuticals annual current liabilities year-on-year change?
Over the past year, PRTK annual total current liabilities has changed by +$6.09 M (+19.46%)
What is Paratek Pharmaceuticals quarterly total current liabilities?
The current quarterly current liabilities of PRTK is $202.62 M
What is the all time high quarterly current liabilities for Paratek Pharmaceuticals?
Paratek Pharmaceuticals all-time high quarterly total current liabilities is $202.62 M
What is Paratek Pharmaceuticals quarterly current liabilities year-on-year change?
Over the past year, PRTK quarterly total current liabilities has changed by +$172.52 M (+573.15%)